ANIP Ani Pharmaceuticals PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ANIP
- PE Ratio
The current PE ratio of ANIP can't be determined, as the TTM EPS of -$0.75 is negative. The most recent PE ratio recorded for Ani Pharmaceuticals was 53.97 in June 2024.
ANIP PE ratio history
Over the last ten years, the average PE ratio of Ani Pharmaceuticals has been 521.24. Over the past ten years, ANIP's PE ratio was at its highest in the Jun 2018 quarter at 6,680, with a price of $66.8 and an EPS of $0.01. The Mar 2016 quarter recorded the bottom point at 31.17, with a price of $33.66 and an EPS of $1.08.
Ani Pharmaceuticals PE ratio by year
Maximum annual increase: 429.36% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $55.28 | -$1.04 |
| 2023 | 64.12 | N/A | $55.14 | $0.86 |
| 2022 | N/A | N/A | $40.23 | -$3.05 |
| 2021 | N/A | N/A | $46.08 | -$3.4 |
| 2020 | N/A | N/A | $29.04 | -$1.88 |
| 2019 | 120.92 | 251.82% | $61.67 | $0.51 |
| 2018 | 34.37 | N/A | $45.02 | $1.31 |
| 2017 | N/A | N/A | $64.45 | -$0.09 |
| 2016 | 178.29 | 429.36% | $60.62 | $0.34 |
| 2015 | 33.68 | 55.85% | $45.13 | $1.34 |
| 2014 | 21.61 | N/A | $56.39 | $2.61 |
| 2013 | N/A | N/A | $20.08 | -$0.92 |
| 2012 | N/A | N/A | $7.38 | -$7.62 |
| 2011 | N/A | N/A | $18.08 | -$18.9 |
| 2010 | N/A | N/A | $59.04 | -$25.26 |
Ani Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | N/A | N/A | $65.25 | -$0.75 |
| Mar 2025 | N/A | N/A | $66.95 | -$1.26 |
| Dec 2024 | N/A | N/A | $55.28 | -$1.04 |
| Sep 2024 | N/A | N/A | $59.66 | -$0.55 |
| Jun 2024 | 53.97 | 26.48% | $63.68 | $1.18 |
| Mar 2024 | 42.67 | -33.45% | $69.13 | $1.62 |
| Dec 2023 | 64.12 | -41.47% | $55.14 | $0.86 |
| Sep 2023 | 109.55 | N/A | $58.06 | $0.53 |
| Jun 2023 | N/A | N/A | $53.83 | -$0.48 |
| Mar 2023 | N/A | N/A | $39.72 | -$1.72 |
| Dec 2022 | N/A | N/A | $40.23 | -$3.05 |
| Sep 2022 | N/A | N/A | $32.14 | -$4.63 |
| Jun 2022 | N/A | N/A | $29.67 | -$4.45 |
| Mar 2022 | N/A | N/A | $28.11 | -$4.68 |
| Dec 2021 | N/A | N/A | $46.08 | -$3.4 |
ANIP Price vs fair value
ANIP average PE ratio chart
PE comparison
ANIP PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| PFE Pfizer Inc | 14.31 | $139.93B |
| NVS Novartis AG | 17.03 | $241.71B |
| RPRX Royalty Pharma plc | 17.5 | $23.57B |
| CAH Cardinal Health Inc | 29.55 | $46.76B |
| JAZZ Jazz Pharmaceuticals plc | N/A | $8.32B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $28.22B |
| CLDX Celldex Therapeutics Inc | N/A | $1.58B |
| ANIP Ani Pharmaceuticals Inc | N/A | $2.01B |
Frequently asked questions
What is Ani Pharmaceuticals's PE ratio?
The current price to earnings ratio of ANIP can't be calculated, as its EPS of -$0.75 is negative.
What is the highest PE ratio for ANIP?
Over the last ten years, the quarterly PE ratio reached a historic high of 6,680 in the Jun 2018 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.